Vivia Biotech
PrivateLast Round
Series A
Apr 16, 2012
Total Funding Raised
$15.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vivia Biotech operates in Healthcare & Life Sciences and is based in Tres Cantos. Its latest recorded funding round was a Series A round in April 2012.
Vivia Biotech is a biotechnology company that provides preclinical and translational contract research services, specializing in ex vivo drug screening on patient samples for oncology and autoimmune drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivia Biotech Comparables
Compare Vivia Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Diag2Tec | 85% | |
| Certis Oncology Solutions | 82% | |
| Champions Oncology | 76% |
For institutional investors. Book with your work email.
Vivia Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 16, 2012 | ||||
| Seed | Nov 1, 2007 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vivia Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sodical Instituto Financiero de Castilla y León | Seed |
| Clave Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 1983% MoM, reaching 1.1K.
- May 15, 2026
Monthly visitors grew 2789% MoM, from 28 to 809.
For institutional investors. Book with your work email.
Vivia Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vivia Biotech's valuation, stock price, and market status.
Is Vivia Biotech a public or private company?
Vivia Biotech is a private company.
What is the current stock price of Vivia Biotech?
Vivia Biotech is a private company, so its shares have no public market price. Caplight tracks Vivia Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vivia Biotech worth (valuation)?
Valuation information for Vivia Biotech is not publicly available.
Can I buy Vivia Biotech stock?
Vivia Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vivia Biotech's last funding round?
Vivia Biotech's most recent funding round was Series A on April 16, 2012.
Who are the main investors in Vivia Biotech?
Key investors in Vivia Biotech include Sodical Instituto Financiero de Castilla y León, Clave Capital.
Will Vivia Biotech IPO soon?
No public IPO plans have been announced for Vivia Biotech.
How can I track Vivia Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Vivia Biotech's shares on secondary markets.